{
  "disease_name": "Hemolytic anemia due to red cell pyruvate kinase deficiency",
  "orpha_code": "766",
  "trials": [
    {
      "nctId": "NCT06213402",
      "briefTitle": "RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)",
      "officialTitle": "A Retrospective/Prospective, Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) With Clinical Significance.",
      "overallStatus": "RECRUITING",
      "studyType": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Sickle Cell Disease",
        "Thalassemia",
        "Hemolytic; Anemia, Hereditary, Due to Enzyme Disorder",
        "Anemia Due to Membrane Defect",
        "CDA",
        "Sideroblastic Anemia",
        "Constitutional Aplastic Anemia",
        "Iron Metabolism Disorders",
        "Hereditary Anemia"
      ],
      "interventions": [
        {
          "type": "OTHER",
          "name": "Data collection from EHR."
        }
      ],
      "enrollment": 32564,
      "locations": [
        {
          "facility": "Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebr√≥n (VHIR/HUVH)",
          "city": "Barcelona",
          "country": "Spain"
        }
      ],
      "lastUpdateDate": "2024-01-19"
    }
  ],
  "processing_timestamp": "2025-07-07T03:14:53.623510",
  "run_number": 1,
  "total_trials_found": 1
}